Structural insights into the clustering and activation of Tie2 receptor mediated by Tie2 agonistic antibody [PDF]
Angiopoietin (Angpt)-Tie receptor 2 (Tie2) regulates vascular stability and is thus a potential therapeutic target in vascular diseases. Here, the authors report a Tie2-agonistic antibody which targets a site distinct from the Angpt 1-binding site and ...
Gyunghee Jo +9 more
doaj +5 more sources
Angpt2/Tie2 autostimulatory loop controls tumorigenesis [PDF]
Invasive nonfunctioning (NF) pituitary neuroendocrine tumors (PitNETs) are non‐resectable neoplasms associated with frequent relapses and significant comorbidities.
Ninelia Minaskan Karabid +20 more
doaj +9 more sources
Efficacy of Tie2 Receptor Antagonism in Angiosarcoma
Angiosarcomas are malignant endothelial cell tumors with few effective systemic treatments. Despite a unique endothelial origin, molecular candidates for targeted therapeutic intervention have been elusive.
Jason R. Hasenstein +6 more
doaj +4 more sources
The angiopoietin receptor Tie2 is atheroprotective in arterial endothelium
AbstractLeukocytes and resident cells in the arterial wall contribute to atherosclerosis, especially at sites of disturbed blood flow. Expression of endothelial Tie1 receptor tyrosine kinase is enhanced at these sites, and attenuation of its expression reduces atherosclerotic burden and decreases inflammation.
Andrey Anisimov +17 more
core +5 more sources
Tyrosine phosphorylation of Grb14 by Tie2 [PDF]
Background Growth factor receptor bound (Grb) proteins 7, 10 and 14 are a family of structurally related multi-domain adaptor proteins involved in a variety of biological processes.
Dumont Daniel J, Sturk Celina
doaj +6 more sources
Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization [PDF]
Significance Tie1 and Tie2 receptor tyrosine kinases are key regulators of blood and lymphatic vessel development and of pathological processes including tumor angiogenesis, atherosclerosis, and vascular leakage, e.g., in sepsis. Tie1 is essential for the Tie2 agonist activity of angiopoietins, and the activated receptors form heteromeric ...
Alitalo Kari +5 more
openaire +4 more sources
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma [PDF]
Due to the usually late diagnosis and lack of effective therapies, hepatocellular carcinoma (HCC), which poses a growing global health problem, is characterized by a poor prognosis. Angiogenesis plays an important role in HCC progression, and vascular endothelial growth factor (VEGF) and angiopoietins (Angs) are key drivers of HCC angiogenesis.
Bart Vanderborght +3 more
openaire +5 more sources
The Angiopoietin-Tie2 Pathway in Critical Illness
Lethal features of sepsis and acute respiratory distress syndrome (ARDS) relate to the health of small blood vessels. For example, alveolar infiltration with proteinaceous fluid is often driven by breach of the microvascular barrier. Spontaneous thrombus formation within inflamed microvessels exacerbates organ ischemia, and in its final stages, erupts ...
Kelsey D, Sack +2 more
openaire +4 more sources
Angiopoietin-1 receptor Tie2 distinguishes multipotent differentiation capability in bovine coccygeal nucleus pulposus cells [PDF]
Background The intervertebral disc (IVD) has limited self-healing potential and disc repair strategies require an appropriate cell source such as progenitor cells that could regenerate the damaged cells and tissues.
Adel Tekari +4 more
doaj +2 more sources
Shear stress control of vascular leaks and atheromas through Tie2 activation by VE‐PTP sequestration
Vascular endothelial protein tyrosine phosphatase (VE‐PTP) influences endothelial barrier function by regulating the activation of tyrosine kinase receptor Tie2.
Keisuke Shirakura +6 more
doaj +2 more sources

